Related Experiment Videos

Plasma malondialdehyde and nitric oxide levels in age related macular degeneration

Y Totan1, O Cekiç, M Borazan

  • 1Department of Ophthalmology, Turgut Ozal Medical Centre, Inönü University School of Medicine, 44300 Malatya, Turkey. ytotan@usa.net

The British Journal of Ophthalmology
|December 6, 2001
PubMed
Abstract

Insights

Patients with exudative age-related macular degeneration (ARMD) show higher levels of malondialdehyde (MDA) and lower levels of nitric oxide (NO). These findings suggest oxidative damage and vascular factors contribute to ARMD development.

Area of Science:

  • Ophthalmology
  • Biochemistry
  • Gerontology

Background:

  • Age-related macular degeneration (ARMD) is a leading cause of vision loss in older adults.
  • Oxidative stress and vascular dysfunction are implicated in the pathogenesis of ARMD.

Purpose of the Study:

  • To investigate plasma levels of malondialdehyde (MDA) and nitric oxide (NO) in patients with exudative ARMD.
  • To assess the role of oxidative damage and vascular factors in ARMD.

Main Methods:

  • Plasma MDA levels, a marker of lipid peroxidation, were measured.
  • Plasma nitrite plus nitrate concentrations, an index of NO levels, were determined.
  • Measurements were compared between patients with exudative ARMD and age/sex-matched healthy controls.

Main Results:

  • Patients with exudative ARMD exhibited significantly elevated plasma MDA levels compared to controls (p=0.01).
  • Patients with exudative ARMD showed significantly reduced plasma NO levels compared to controls (p=0.001).

Conclusions:

  • The study findings support the involvement of oxidative damage in the pathogenesis of ARMD.
  • Results suggest that vascular theories, potentially linked to the aging process, may contribute to ARMD development.

Related Concept Videos